n-(3-pyridylmethyl)adriamycin has been researched along with Inflammation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fleming, EL; Perlman, S; Trujillo, JA | 1 |
1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and Inflammation
Article | Year |
---|---|
Transgenic CCL2 expression in the central nervous system results in a dysregulated immune response and enhanced lethality after coronavirus infection.
Topics: Animals; B7-2 Antigen; Brain; CD4-Positive T-Lymphocytes; CD40 Antigens; Chemokine CCL2; Coronavirus Infections; Doxorubicin; Forkhead Transcription Factors; Histocompatibility Antigens Class II; Immunosuppression Therapy; Inflammation; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Murine hepatitis virus; Nitric Oxide | 2013 |